Table of Contents Table of Contents
Previous Page  303 / 412 Next Page
Information
Show Menu
Previous Page 303 / 412 Next Page
Page Background

10.

Patil PG, Turner DA, Pietrobon R. National trends in surgical procedures for degenerative cervical spine disease: 1990-2000 . Neurosurgery . 2005; 57:753–758. discussion 753–758.

11.

Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery . N Engl J Med . 2011;364: 2128–2137.

12.

Yung KC, Courey MS. The Effect of office-based flexible endoscopic sur- gery on hemodynamic stability . Laryngoscope . 2010;120:2231–2236.

13.

Mathison CC, Villari CR, Klein AM, Johns MM 3rd. Comparison of out- comes and complications between awake and asleep injection laryngo- plasty: a case-control study . Laryngoscope . 2009;119:1417–1423.

14.

Yung KC, Likhterov I, Courey MS. Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients . Laryngoscope . 2011;121: 2191–2194.

15.

Friedman AD, Burns JA, Heaton JT, Zeitels SM. Early versus late injection medialization for unilateral vocal cord paralysis . Laryngoscope . 2010;120: 2042–2046.

16.

Arviso LC, Johns MM 3rd, Mathison CC, Klein AM. Long-term outcomes of injection laryngoplasty in patients with potentially recoverable vocal fold paralysis . Laryngoscope . 2010;120:2237–2240.

17.

Ford CN, Roy N, Sandage M, Bless DM. Rigid endoscopy for monitoring indirect vocal fold injection . Laryngoscope . 1998;108:1584–1586.

18.

Ward PH, Hanson DG, Abemayor E. Transcutaneous Teflon injection of the paralyzed vocal cord: a new technique . Laryngoscope . 1985;95: 644–649.

19.

Amin MR. Thyrohyoid approach for vocal fold augmentation . Ann Otol Rhinol Laryngol . 2006;115:699–702

.

20.

Dedo HH, Urrea RD, Lawson L. Intracordal injection of Teflon in the treat- ment of 135 patients with dysphonia . Ann Otol Rhinol Laryngol . 1973;82: 661–667.

21.

Grant JR, Hartemink DA, Patel N, Merati AL. Acute and subacute awake injection laryngoplasty for thoracic surgery patients . J Voice . 2008;22: 245–250.

22.

Bove MJ, Jabbour N, Krishna P, et al. Operating room versus office-based injection laryngoplasty: a comparative analysis of reimbursement . Laryn- goscope . 2007;117:226–230.

23.

Andrade Filho PA, Carrau RL, Buckmire RA. Safety and cost- effectiveness of intra-office flexible videolaryngoscopy with transoral vocal fold injection in dysphagic patients . Am J Otolaryngol . 2006;27: 319–322.

24.

Lee SW, Kim JW, Chung CH, et al. Utility of injection laryngoplasty in the management of post-thyroidectomy vocal cord paralysis . Thyroid . 2010;20: 513–517.

25.

Damrose EJ. Percutaneous injection laryngoplasty in the management of acute vocal fold paralysis . Laryngoscope . 2010;120:1582–1590.

26.

Graboyes EM, Bradley JP, Meyers BF, Nussenbaum B. Efficacy and safety of acute injection laryngoplasty for vocal cord paralysis following thoracic surgery . Laryngoscope . 2011;121:2406–2410.

27.

Bhattacharyya N, Kotz T, Shapiro J. Dysphagia and aspiration with unilat- eral vocal cord immobility: incidence, characterization, and response to surgical treatment . Ann Otol Rhinol Laryngol . 2002;111:672–679.

28.

Mau T, Courey MS. Influence of gender and injection site on vocal fold augmentation . Otolaryngol Head Neck Surg . 2008;138:221–225.

29.

Perazzo PS, Duprat Ade C, Lancellotti CL. Histological behavior of the vocal fold after hyaluronic acid injection . J Voice . 2009;23:95–98.

30.

Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmen- tation . Dermatol Surg . 2002;28:491–494.

31.

Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hy- aluronic acid gel . Dermatol Surg . 2000;26:135–137.

32.

Soparkar CN, Patrinely JR. Managing inflammatory reaction to restylane . Ophthal Plast Reconstr Surg . 2005;21:151–153.

33.

Chheda NN, Rosen CA, Belafsky PC, Simpson CB, Postma GN. Revision laryngeal surgery for the suboptimal injection of calcium hydroxylapatite . Laryngoscope . 2008;118:2260–2263.

34.

Luu Q, Tsai V, Mangunta V, Berke GS, Chhetri DK. Safety of percutaneous injection of bovine dermal crosslinked collagen for glottic insufficiency . Otolaryngol Head Neck Surg . 2007;136:445–449.

35.

Crumley RL. Experiments in laryngeal reinnervation . Laryngoscope . 1982; 92(9 Pt 2 suppl 30):1–27.

36.

Crumley RL. Laryngeal synkinesis: its significance to the laryngologist . Ann Otol Rhinol Laryngol . 1989;98:87–92.

37.

Crumley RL. Laryngeal synkinesis revisited . Ann Otol Rhinol Laryngol . 2000;109:365–371.

38.

Carroll TL, Rosen CA. Long-term results of calcium hydroxylapatite for vocal fold augmentation . Laryngoscope . 2011;121:313–319.

39.

Tan M, Woo P. Injection laryngoplasty with micronized dermis: a 10-year experience with 381 injections in 344 patients . Laryngoscope . 2010;120: 2460–2466.

40.

Sulica L. The natural history of idiopathic unilateral vocal fold paralysis: evidence and problems . Laryngoscope . 2008;118:1303–1307.

Journal of Voice, Vol. 28, No. 3, 2014

78